
Drugmakers’ Secret Weapon To Keep Your Meds Overpriced
Big drugmakers are abusing the drug patent process to generate extra revenue at the cost of patients, according to a new report.
Deep dives into the political corruption and corporate bureaucracy that keeps Americans sick while making executives rich.
Big drugmakers are abusing the drug patent process to generate extra revenue at the cost of patients, according to a new report.
UnitedHealth Group’s investors were profiting from its high denial rates. Now, they’re suing to ensure that doesn’t change.
Federal regulators have authorized hundreds of drugs without evidence they work, and many are dangerous.
Health and Human Services Secretary Robert F. Kennedy Jr. is ushering in a new era of secrecy at the FDA.
Blue Cross Blue Shield just made it harder for many patients to get vital asthma and allergy medications — all while channeling more profits toward a PBM-affiliated pharmacy.
Nonprofit hospitals are building tax-exempt real estate empires — and working to crush politicians who stand in their way.
Many beauty products include talc, which has been shown to be contaminated with a dangerous toxin. Here’s how to avoid the risk.
Warren Buffett’s conglomerate owns a company that profited off a cancer-linked makeup ingredient. Now the firm aims to create a legal precedent — and deny victims remuneration.
Google’s monopoly status is questioned, states can sue for climate cleanup, a judge tells Trump to do his research, and a zombie pipeline is stopped in its tracks.
Aid money starts to flow, vital youth care is affirmed, a radical housing plan takes root, and desert water gets revolutionized.